Yandan Ren

769 total citations
18 papers, 518 citations indexed

About

Yandan Ren is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Yandan Ren has authored 18 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Yandan Ren's work include Liver Disease Diagnosis and Treatment (3 papers), Epigenetics and DNA Methylation (3 papers) and Hepatitis B Virus Studies (3 papers). Yandan Ren is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Epigenetics and DNA Methylation (3 papers) and Hepatitis B Virus Studies (3 papers). Yandan Ren collaborates with scholars based in China, Singapore and Taiwan. Yandan Ren's co-authors include Jin‐Shui Pan, Mei‐Zhu Hong, Guiqin Hou, Zhaoming Lu, Jianlin Ren, Xuan Dong, Wei-Ming Chen, Danyi Zeng, Yanyan Cai and Kuangnan Fang and has published in prestigious journals such as Advanced Functional Materials, Hepatology and Scientific Reports.

In The Last Decade

Yandan Ren

17 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yandan Ren China 12 285 187 109 103 89 18 518
Te‐Sheng Chang Taiwan 14 154 0.5× 305 1.6× 33 0.3× 109 1.1× 278 3.1× 50 678
Yi‐Ying Wu Taiwan 15 209 0.7× 137 0.7× 27 0.2× 56 0.5× 94 1.1× 21 641
G.C. Naccari Italy 5 218 0.8× 175 0.9× 38 0.3× 52 0.5× 30 0.3× 5 762
Lubiao Chen China 12 181 0.6× 202 1.1× 35 0.3× 80 0.8× 167 1.9× 37 470
Yun Liao China 12 232 0.8× 80 0.4× 23 0.2× 62 0.6× 35 0.4× 18 508
Sho Fujiwara Japan 10 120 0.4× 112 0.6× 61 0.6× 124 1.2× 92 1.0× 33 519
Richard D. Horniblow United Kingdom 10 184 0.6× 73 0.4× 38 0.3× 28 0.3× 49 0.6× 20 458

Countries citing papers authored by Yandan Ren

Since Specialization
Citations

This map shows the geographic impact of Yandan Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yandan Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yandan Ren more than expected).

Fields of papers citing papers by Yandan Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yandan Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yandan Ren. The network helps show where Yandan Ren may publish in the future.

Co-authorship network of co-authors of Yandan Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Yandan Ren. A scholar is included among the top collaborators of Yandan Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yandan Ren. Yandan Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Su, Jingling, et al.. (2024). Class A1 scavenger receptor antibody improves murine colitis by influencing macrophage and gut microbiota. Scientific Reports. 14(1). 18618–18618. 2 indexed citations
2.
Han, Yang, Yueting Gu, Yandan Ren, et al.. (2024). RILP Induces Cholesterol Accumulation in Lysosomes by Inhibiting Endoplasmic Reticulum–Endolysosome Interactions. Cells. 13(16). 1313–1313.
3.
Zhou, Yüxia, Ziyan Wang, Jun Chen, et al.. (2023). Rab26 restricts insulin secretion via sequestering Synaptotagmin-1. PLoS Biology. 21(6). e3002142–e3002142. 5 indexed citations
4.
Li, Lihuang, Shuntian Cai, Yandan Ren, et al.. (2023). Tumbler‐Inspired Microneedle Containing Robots: Achieving Rapid Self‐Orientation and Peristalsis‐Resistant Adhesion for Colonic Administration. Advanced Functional Materials. 33(43). 22 indexed citations
5.
Su, Jingling, et al.. (2022). Decreased serum iron concentration and total iron binding capacity are associated with serious Crohn’s disease. Scientific Reports. 12(1). 3923–3923. 1 indexed citations
6.
Zeng, Danyi, Su Lin, Xuan Dong, et al.. (2021). Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990–2019. Journal of Hepatology. 75(3). 547–556. 98 indexed citations
7.
Zhou, Jingping, Yandan Ren, Qinyu Xu, et al.. (2020). Obesity‐Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1. BioMed Research International. 2020(1). 4087928–4087928. 12 indexed citations
8.
Lu, Zhaoming, Xiaojing Shi, Fanghua Gong, et al.. (2020). RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma. Acta Pharmaceutica Sinica B. 10(6). 1004–1019. 23 indexed citations
9.
Lu, Zhaoming, Yandan Ren, Li Yang, et al.. (2020). Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting NRF2 in esophageal squamous cell carcinoma. Acta Pharmaceutica Sinica B. 11(5). 1246–1260. 40 indexed citations
10.
Dong, Xuan, Yandan Ren, Wei-Ming Chen, et al.. (2020). Liver Chemistries in Patients With COVID-19 Who Were Discharged Alive or Died: A Meta-analysis. Hepatology Communications. 5(1). 12–23. 9 indexed citations
11.
Hou, Guiqin, Yi‐Ru Bai, Yandan Ren, et al.. (2020). Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin. Canadian Journal of Physiology and Pharmacology. 98(7). 449–458. 16 indexed citations
12.
Hou, Guiqin, Qi Zhao, Mengying Zhang, et al.. (2019). <p>LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma</p>. OncoTargets and Therapy. Volume 12. 5215–5225. 16 indexed citations
13.
Su, Jingling, et al.. (2019). Elevated serum triglyceride and low-density lipoprotein cholesterol promotes the formation of colorectal polyps. BMC Gastroenterology. 19(1). 195–195. 26 indexed citations
14.
Lu, Zhaoming, Yandan Ren, Mengying Zhang, et al.. (2018). FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells. Biomedicine & Pharmacotherapy. 107. 1370–1376. 23 indexed citations
15.
Hou, Guiqin, Qi Zhao, Mingjie Zhang, et al.. (2018). Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy. 106. 1348–1356. 29 indexed citations
16.
Hong, Mei‐Zhu, Linglong Ye, Lixin Jin, et al.. (2017). Noninvasive scoring system for significant inflammation related to chronic hepatitis B. Scientific Reports. 7(1). 43752–43752. 4 indexed citations
17.
Ma, Huabin, Jin‐Shui Pan, Lixin Jin, et al.. (2016). MicroRNA-17~92 inhibits colorectal cancer progression by targeting angiogenesis. Cancer Letters. 376(2). 293–302. 63 indexed citations
18.
Ren, Yandan, Lixin Jin, Wenjun Wei, et al.. (2016). Fecal microbiota transplantation induces hepatitis B virus e‐antigen (HBeAg) clearance in patients with positive HBeAg after long‐term antiviral therapy. Hepatology. 65(5). 1765–1768. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026